StonvexLoading…
StonvexStonvexStonvexCore line items from ALGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.19M | $3.61M | $6.19M | $0.00 |
Operating Income | $-87.98M | $-89.15M | $-88.13M | $-97.58M |
Net Income | $-24.19M | $-131.21M | $-87.68M | $-96.05M |
EPS (Diluted) | $-2.45 | $-20.94 | $-34.20 | $-2.25 |
Total Assets | $88.53M | $70.09M | $151.53M | $146.69M |
Total Liabilities | $34.99M | $99.07M | $59.45M | $42.79M |
Cash & Equivalents | $18.30M | $37.00M | $135.70M | $81.35M |
Free Cash Flow OCF − CapEx | Not available | $-80.87M | $-79.02M | $-80.33M |
Shares Outstanding | 6.18M | 3.86M | 3.00M | 42.92M |